                         SEQUENCE LISTING

<110>  GSK Consumer Healthcare SARL
 
<120>  ANTIVIRAL PHARMACEUTICAL COMPOSITION

<130>  CB66929 FF

<150>  EP20183324.1
<151>  2020-06-30

<160>  3     

<170>  PatentIn version 3.5

<210>  1
<211>  20
<212>  DNA
<213>  Artificial

<220>
<223>  Primer

<400>  1
tggggyttta crggtaacct                                                   20


<210>  2
<211>  21
<212>  DNA
<213>  Artificial

<220>
<223>  Primer

<400>  2
aacrcgctta acaaagcact c                                                 21


<210>  3
<211>  24
<212>  DNA
<213>  Artificial

<220>
<223>  Probe

<400>  3
tagttgtgat gcwatcatga ctag                                              24


